Berenberg Bank reaffirmed their hold rating on shares of Pfizer (NYSE:PFE) in a research note issued to investors on Tuesday, Analyst Price Targets reports. The brokerage currently has a $54.00 price target on the biopharmaceutical company’s stock.
Berenberg Bank reaffirmed their hold rating on shares of Pfizer (NYSE:PFE) in a research note issued to investors on Tuesday, Analyst Price Targets reports. The brokerage currently has a $54.00 price target on the biopharmaceutical company’s stock.